Pharmaceutical

SyntheticGestalt and Enamine partner on AI drug discovery models

SyntheticGestalt and Enamine have announced a collaboration to develop a suite of AI models to aid in the discovery of drugs.

Jan 13, 2024 - 18:00
SyntheticGestalt and Enamine partner on AI drug discovery models
SyntheticGestalt and Enamine have announced a collaboration to develop a suite of AI models to aid in the discovery of drugs.
Read the original article

Tags:

Previous Article

Cereno partners with CordenPharma to scale up CS1 drug production

Next Article

Q&A: Exploring the challenges behind oncology trials

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA’s warning to J&J’s Abiomed signals a crackdown on digital health tools

STAT+: FDA’s warning to J&J’s Abiomed signals a crackdo...

Oct 16, 2023

Amgen and AstraZeneca ponder label expansion for Tezspire in COPD

Amgen and AstraZeneca ponder label expansion for Tezspi...

May 21, 2024

AstraZeneca scores its second paediatric approval for Soliris in Japan

AstraZeneca scores its second paediatric approval for S...

Aug 26, 2023